Pesticides Outlawed in the 1970s Are Still in Women's Blood, and They Track With Chronic Inflammation

I used to think a chemical ban came with an expiration date on the danger. Regulators decide a pesticide is too toxic to sell, they pull it off the shelves, and after a decent interval the problem drains out of the world the way a bad smell finally leaves a room. Then I read what French scientists found in the blood of 468 women: pesticides the government outlawed back when bell-bottoms were in style, still circulating decades later, still keeping company with an inflamed body. My mental model was almost completely wrong.

The new analysis of the French E3N-Generations cohort, published in Environmental Health, screened 45 persistent organic pollutants in the blood of 468 women and asked one blunt question: do these chemicals track with signs that the body is inflamed? The blood was drawn between 1994 and 1999, from women aged 45 to 73. Several of the compounds on the list had already been banned for a generation by the time those tubes were filled.

The two pesticides that clung most stubbornly to inflammation were dieldrin and cis-heptachlor epoxide. The EPA cancelled nearly all uses of dieldrin and heptachlor starting in 1974, and the last termite uses were gone by the late 1980s. cis-heptachlor epoxide is what the body and the soil make out of heptachlor, the breakdown product that outlasts the parent compound. In the E3N women, both stayed significantly associated with elevated C-reactive protein, the workhorse marker of systemic inflammation, even after a false-discovery-rate correction meant to strip out statistical noise.

The reason is unglamorous and physical. Organochlorines like dieldrin and heptachlor epoxide are fat-soluble and slow to metabolize, so the body does not flush them. It files them away in adipose tissue, where they sit for years and leach back into circulation. A ban stops new exposure. It does nothing about the reservoir already stored in a woman’s fat, so the outlawed chemical and the living body stay in contact long after the paperwork says the story is over.

Then the study turned in the opposite direction. Several PFAS, the “forever chemicals,” were inversely associated with interleukin-8, another inflammation signal. Higher PFAS, lower IL-8. The pattern held most firmly for PFDA, PFNA, and PFOS after correction. My first instinct was to squint at it: wait, why would a forever chemical push an inflammation marker down? Isn’t less inflammation the thing we want?

Not here. Follow the biology and a quieter immune signal in the presence of PFAS is not the body healing. It is the body being muffled. The systematic evidence on PFAS immunotoxicity is hard to wave off: across a large body of human and animal studies, these compounds cut circulating antibodies and blunt T-cell and B-cell responses. It lines up with the repeated finding that people carrying more PFAS mount weaker antibody responses to vaccines. So a drop in IL-8 fits the immunosuppressive fingerprint rather than contradicting it. The old banned pesticides look like they stoke inflammation; the newer, still barely regulated PFAS look like they smother part of the immune response. Two chemical classes, two kinds of damage, sitting in the same 468 bloodstreams.

This is not the first crack in the picture, which is what gives it weight. An earlier E3N analysis of the same blood samples tied these pollutants to oxidative-stress enzymes, with the detox enzyme GST-alpha rising and the antioxidant SODs drifting down, the biochemical texture of cells under chronic strain. A separate profiling paper mapped how much these women were carrying: a broad mix of PFAS, organochlorine pesticides, PCBs, and flame retardants turning up across the samples. Different markers, same cohort, one direction.

I want to be square about what this design can and cannot show. It is a cross-sectional snapshot, and the team modeled the inflammation markers as high-versus-low categories rather than continuous effect sizes, so it demonstrates association, not that the chemical caused the inflammation. The tension in the literature is the productive part. A large Swedish cohort of 70-year-olds, the PIVUS study, ran the same kind of test and found POPs strongly tied to vascular adhesion molecules like ICAM-1, the top signal landing at p = 3.6 x 10⁻⁵ and driven by the dioxin-like PCB-126, yet found no link to CRP at all. The specific marker that lights up moves with the population and the chemical mix. What does not move, study to study, is that this stuff gets into the body and the body reacts.

The reflex from the chemical industry and its regulators has always been that the dose makes the poison and that banned compounds are yesterday’s problem. This cohort is a quiet rebuttal to both. These are population-level body burdens in ordinary women, not factory-floor exposures. The bans were real and they mattered, but they came late, and they do not reach backward into the fat cells of everyone already carrying the residue. And the PFAS, the class wearing the immunosuppressive signature here, are the ones we are still arguing about whether to regulate at all. This was publicly funded work, with no industry money behind it and no competing interests declared, which is worth saying out loud given how many of the reassuring studies in this field cannot say the same.

So what do I do with this? I am not going to pretend one cohort rewrites my life. But I have stopped treating “it was banned decades ago” as a synonym for “it is gone,” and I would press my representatives on PFAS limits in drinking water without waiting for the perfect prospective trial, because the immunotoxicity evidence, the weaker vaccine responses most of all, is already strong enough to act on. The chemicals in these women’s blood did not ask permission, and they did not read the memo about being retired. So I am not waiting on permission either: I filter my tap water, I am choosier about nonstick and stain-proof coatings, and I would not roll my eyes at any of it now.

Sources

1. Environmental Health: inflammation and persistent pollutants in the E3N-Generations cohort (2026)
2. Environmental Research: POPs and oxidative-stress biomarkers in E3N women (2025)
3. Environmental Research: blood POP profiles and determinants in E3N women (2024)
4. Environmental Health Perspectives: POPs and inflammatory markers, PIVUS cohort of elderly Swedes (2014)
5. Systematic evidence: PFAS, chronic inflammation, and immunosuppression (2023)
6. ATSDR Toxicological Profile for Aldrin/Dieldrin: regulatory history and persistence in body fat
7. ATSDR Toxicological Profile for Heptachlor and Heptachlor Epoxide: cancellation history